Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60da379fb33c192ef77f86a60c5ac029 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2005-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001ba405746b2bfa10ad8776925ae8e3 |
publicationDate |
2006-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006040284-A1 |
titleOfInvention |
TMS1 compositions and methods of use |
abstract |
The invention relates to the identification of a novel gene, TMS1, which is transcriptionally silenced as a result of methylation. Nucleic acids and polypeptides are provided as are methods and tools for diagnosing and treating disorders characterized by such methylation, and/or abnormally low levels of TMS1 expression products. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010297067-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010298255-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008143896-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004224972-A1 |
priorityDate |
1999-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |